Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ZEVRA THERAPEUTICS, INC.KMPH · Entity 5212 | EVP, Govt. & Public Relations | May 15, 2018 | May 17, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ZEVRA THERAPEUTICS, INC.
Report date May 15, 2018 · Filed May 17, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 35,500 |
Reported balance
After 2018-05-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-05-15 · Purchase · Acquired 5,500 · Balance 35,500 |
| Common StockSEC Table I · non-derivative | Direct | 2,000 |
Reported balance
After 2018-05-15 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-05-15 · Purchase · Acquired 2,000 · Balance 2,000 F1: Held jointly with spouse. |
| Common StockSEC Table I · non-derivative | IndirectBy Daughter. | 1,450 |
Reported balance
After 2018-05-15 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-05-15 · Purchase · Acquired 200 · Balance 1,450 F2: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares. |
| Common StockSEC Table I · non-derivative | IndirectBy Daughter. | 1,450 |
Reported balance
After 2018-05-15 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2018-05-15 · Purchase · Acquired 200 · Balance 1,450 F3: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Held jointly with spouse.
F2: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.
F3: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2018 Filed May 17, 2018 21:18 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 200 | $6.45 | $1,290.00 |
DisclosureSEC source: 0001437749-18-010288 · rdgdoc.xml · nonDerivative · entry 4 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter. Disclosed balance after: 1,450 F3 · ownership.direct: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:18 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 200 | $6.45 | $1,290.00 |
DisclosureSEC source: 0001437749-18-010288 · rdgdoc.xml · nonDerivative · entry 3 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter. Disclosed balance after: 1,450 F2 · ownership.direct: The shares are held in a trust for the benefit of the Reporting Person's daughter. The Reporting Person's spouse is trustee of the trust. The Reporting Person may be deemed to have indirect beneficial interest in such shares. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:18 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 2,000 | $6.45 | $12,891.00 |
DisclosureSEC source: 0001437749-18-010288 · rdgdoc.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · ownership.direct: Held jointly with spouse. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:18 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 5,500 | $6.45 | $35,450.25 |
DisclosureSEC source: 0001437749-18-010288 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,500 Read SEC document |
| January 25, 2018 Filed Jan 29, 2018 18:56 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001437749-18-001305 · rdgdoc.xml · derivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 25, 2019 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant. Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 7 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter. Disclosed balance after: 1,250 F2 · ownership.direct: The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account. Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | GiftCommon Stock | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 6 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Indirect · By Daughter. Disclosed balance after: 1,250 F1 · ownership.direct: The shares are held in an investment account for the benefit of the Reporting Person's daughter. The Reporting Person may be deemed to have indirect beneficial interest in such shares based on his investment control over the daughter's account. Read SEC document |
| November 29, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | GiftCommon Stock | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 5 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 2,055 | $3.85 | $7,911.75 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 4 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,500 Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 2,990 | $3.80 | $11,362.00 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 3 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,445 Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,310 | $3.75 | $4,912.50 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,455 Read SEC document |
| November 27, 2017 Filed Nov 29, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,145 | $3.70 | $4,236.50 |
DisclosureSEC source: 0001437749-17-019919 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,145 Read SEC document |
| August 24, 2017 Filed Aug 25, 2017 16:32 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 5,000 | $2.58 | $12,882.00 |
DisclosureSEC source: 0001437749-17-015335 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:05 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 526 | $4.14 | $2,180.22 |
DisclosureSEC source: 0001437749-17-010179 · rdgdoc.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| May 25, 2017 Filed May 26, 2017 16:05 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,974 | $4.10 | $8,093.40 |
DisclosureSEC source: 0001437749-17-010179 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,474 Read SEC document |
| March 31, 2017 Filed Mar 31, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,000 | $4.70 | $4,700.00 |
DisclosureSEC source: 0001437749-17-005785 · rdgdoc.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,500 Read SEC document |
| March 29, 2017 Filed Mar 31, 2017 16:24 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,500 | $4.33 | $6,502.05 |
DisclosureSEC source: 0001437749-17-005785 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Read SEC document |
| January 27, 2017 Filed Jan 31, 2017 17:06 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001437749-17-001395 · rdgdoc.xml · derivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt. & Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2027-01-26 F1 · derivative.exercise_date: Grant to the Reporting Person of a stock option under the Issuer's 2014 Equity Incentive Plan (the "Plan"). 25% of the shares will vest on January 27, 2018 and the remaining 75% of the shares will vest in equal annual installments thereafter, provided that at the relevant vesting dates such optionee's employment relationship has not been terminated as defined in the Plan. All shares underlying the option will vest in full and become immediately exercisable upon a change of control of the Issuer or if the Reporting Person is terminated without cause or resigns for good reason. The option expires ten years after the date of grant. Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 09:00 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 4,253 | $3.50 | $14,885.50 |
DisclosureSEC source: 0001562180-16-003645 · primarydocument.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| November 30, 2016 Filed Dec 2, 2016 09:00 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 747 | $3.48 | $2,595.83 |
DisclosureSEC source: 0001562180-16-003645 · primarydocument.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,747 Read SEC document |
| September 06, 2016 Filed Sep 7, 2016 16:22 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 3,690 | $5.01 | $18,490.59 |
DisclosureSEC source: 0001437749-16-038425 · rdgdoc.xml · nonDerivative · entry 5 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 16:22 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,000 | $4.60 | $4,599.90 |
DisclosureSEC source: 0001437749-16-038425 · rdgdoc.xml · nonDerivative · entry 4 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,310 Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 16:22 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 2,000 | $4.59 | $9,187.80 |
DisclosureSEC source: 0001437749-16-038425 · rdgdoc.xml · nonDerivative · entry 3 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,310 Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 16:22 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 2,000 | $4.59 | $9,179.80 |
DisclosureSEC source: 0001437749-16-038425 · rdgdoc.xml · nonDerivative · entry 2 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,310 Read SEC document |
| September 02, 2016 Filed Sep 7, 2016 16:22 UTC | ZEVRA THERAPEUTICS, INC. KMPH · Entity 5212 | PurchaseCommon Stock | 1,310 | $4.59 | $6,012.77 |
DisclosureSEC source: 0001437749-16-038425 · rdgdoc.xml · nonDerivative · entry 1 Cohen Daniel L · CIK 0001672300 · EVP, Govt and Public Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,310 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.